Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial
Stocks

Results: Nifty Companies Show 8.7% growth in Net Profit for Q4 2016, Annual Growth at 0.7%

Results.png

With this results report card, today marks the end of the Earnings Season for the financial year 2015-16. Not all results were as expected, but there have been a lot of surprising results both on the positive and negative end. Here is a summary of how the results panned out for the 50 companies.

Results

Nifty 50 Companies FY16 Results for the year ended March 31, 2016

  • Aurobindo Pharma: Drug maker Auro Pharma reported a 16.9% growth in Revenue for the quarter ended March, 2016. Compared to other Pharma companies on the Nifty, Auro reported better numbers than Dr. Reddy’s for the quarter ended March, 2016. However, the company posted the best results for the year ended March, 2016: 25.8% growth in NP while that of its counterparts stood at -9.8% Dr. Reddy’s, -5.5% Lupin and 3.9% Sun Pharma.
  • Mahindra & Mahindra: Not great results from the Mahindra group as the company missed analysts’ expectations on profit & operational front. Consolidated NP grew 2.4% at Rs. 3,211 cr while Revenue grew by 7.3% at Rs. 67,986 cr. Consolidated EPS grew by 2% from Rs. 50.69/- to Rs. 51.70/-. The company forsees that with a robust monsoon season predicted for this year, rural demand will pick up pace in coming quarters. 
  • Sun Pharmaceutical Industries: The company’s quarterly results were better than the annual results. While the quarter ended NP grew by 92.7% at Rs. 1,714 cr, its NP for the year ended stood at Rs. 4,716 cr – a timid growth of 4%. Taro Pharmaceutical Industries, the US unit of Sun Pharma, reported weak fourth-quarter earnings. The company is in the news after its US arm received a summons from the antitrust division of the US department of Justice. The company said that the earnings in Q4 FY 15 were impacted due to one time charges related to Ranbaxy merger and price erosion in certain products.
  • Tata Motors: The company posted a three fold increase in Net Profits due to stronger operating performance in both standalone as well as Jaguar Land Rover business and lower net finance expenses. On a standalone basis, the company reported Net Profit of Rs. 5,177 cr (+200% compared to 1,717 cr during the same quarter of the previous year). Its British luxury marquee Jaguar Land Rover reported a PAT of 472 million pounds compared to 302 million pound during the same quarter of the previous year.

Nifty 50 Companies FY16 Results for the year ended March 31, 2016 (50)

Nifty 50 Companies FY16 Results for the quarter ended March 31, 2016

Nifty 50 Companies FY16 Results for the quarter ended March 31, 2016 (50)

divider

Disclaimer

Nothing in this newsletter is financial advice and should not be construed as such. Please do not take trading decisions based solely on the matter above; if you do, it is entirely at your own risk without any liability to Capital Mind. This is educational or informational matter only, and is provided as an opinion. 

  • Sidhu Ram says:

    Which of these two charts is final? I see the same title “Nifty 50 Companies FY16 Results for the quarter ended March 31, 2016” for both the charts and the data is entirely different in both!

    • Aakash says:

      Hi Sidhu,
      The first chart contains the annual numbers while the second one contains the quarterly numbers. The table headers are correct. The first chart is titled “Nifty 50 Companies FY16 Results for the year ended March 31, 2016” while the second one is titled “Nifty 50 Companies FY16 Results for the quarter ended March 31, 2016”
      Hope it is clear now!